Sigilon Therapeutics, Inc. Revenue 2021-2023 | SGTX
Sigilon Therapeutics, Inc. revenue from 2021 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Sigilon Therapeutics, Inc. Annual Revenue (Millions of US $) |
|
|---|---|
| 2022 | $13 |
| 2021 | $10 |
| 2020 | $13 |
| 2019 | $14 |
| Sigilon Therapeutics, Inc. Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2023-06-30 | $6 |
| 2023-03-31 | $5 |
| 2022-12-31 | $3 |
| 2022-09-30 | $4 |
| 2022-06-30 | $3 |
| 2022-03-31 | $3 |
| 2021-12-31 | $2 |
| 2021-09-30 | $2 |
| 2021-06-30 | $3 |
| 2021-03-31 | $3 |
| 2020-12-31 | $4 |
| 2020-09-30 | $4 |
| 2020-06-30 | $2 |
| 2020-03-31 | $3 |
